Perspective
Published on 20 Sep 2023
Evaluating treatments in rare indications warrants a Bayesian approach
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1249611
- 1,499 views
- 1 citation
Type at least 3 characters
1,897 articles
Articles
Original Research
Published on 18 Sep 2023
The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1228148
- 5,004 views
- 3 citations
Hypothesis and Theory
Published on 15 Sep 2023
Approach to machine learning for extraction of real-world data variables from electronic health records
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1180962
- 6,464 views
- 11 citations
Original Research
Published on 13 Sep 2023
Acceptance rate of clinical pharmacists’ recommendations—an ongoing journey for integration
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1253990
- 1,872 views
- 2 citations
Original Research
Published on 13 Sep 2023
SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1155210
- 1,746 views
Systematic Review
Published on 11 Sep 2023
Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1227787
- 3,223 views
Methods
Published on 11 Sep 2023
A change point-based analysis procedure for improving the success rate of decision-making in clinical trials with delayed treatment effects
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1186456
- 1,038 views
- 2 citations
Systematic Review
Published on 07 Sep 2023
Effectiveness of decision support tools on reducing antibiotic use for respiratory tract infections: a systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1253520
- 2,072 views
- 1 citation
Original Research
Published on 07 Sep 2023
The participation of clinical pharmacists in the treatment of patients with central nervous system infection can improve the effectiveness and appropriateness of anti-infective treatments: a retrospective cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1226333
- 1,631 views
- 2 citations
Original Research
Published on 07 Sep 2023
Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1219694
- 1,525 views
- 2 citations
Original Research
Published on 05 Sep 2023
A quasi-experimental study of the volume-based procurement (VBP) effect on antiviral medications of hepatitis B virus in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.984794
- 1,891 views
Original Research
Published on 05 Sep 2023
Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1237717
- 5,110 views
- 2 citations
Systematic Review
Published on 01 Sep 2023
Comparative effect of antihypertensive drugs in improving arterial stiffness in adults with hypertension (RIGIPREV study). A network meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1225795
- 2,322 views
- 4 citations
Clinical Trial
Published on 01 Sep 2023
Intraoperative slow-release dexamethasone intravitreal implant (Ozurdex) in epiretinal membrane peeling surgery: a prospective randomized controlled trial
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1219861
- 1,448 views
Review
Published on 31 Aug 2023
The challenges of access to innovative medicines with limited evidence in the European Union
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1215431
- 2,937 views
Original Research
Published on 31 Aug 2023
Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1238009
- 2,457 views
- 1 citation